4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-016416
EVP, CHIEF FINANCIAL OFFICER sold 975 shares at $14.79 ($14,420)
- EVP, CHIEF FINANCIAL OFFICER acquired 1,893 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-06-08 | Option exercise | +1,893 | 35,539 | D | ||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-06-10 | Sale | −975 | $14.79 | $14,420 | 34,564 | D |
| Derivatives | |||||||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-06-08 | Option exercise · Restricted Stock Units | −1,893 | 0 | D | ||
| Open-market sales · 975 sh · avg $14.79 · $14,420 | |||||||
Loading xslF345X05/form4-06112024_060601.xml…